Corticotropin for acute management of gout

C. T. Taylor, N. C. Brooks, K. W. Kelley

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations


OBJECTIVE: To evaluate safety and efficacy of corticotropin for acute gout. DATA SOURCES: Clinical literature was accessed through MEDLINE (1966 - August 2000). Key search terms included gout, ACTH, adrenocorticotropic hormone, and corticotropin. DATA SYNTHESIS: Joint pain and local signs of inflammation characterize gout. Acutely, colchicine and nonsteroidal antiinflammatory drugs (NSAIDs) are first-line therapy. Adverse effects or concomitant diseases limit therapy and necessitate alternative options. An evaluation of studies involving corticotropin was conducted. CONCLUSIONS: Corticotropin alone or in combination with colchicine was more rapidly effective and associated with fewer adverse effects than indomethacin. This regimen may be considered an alternative, especially for patients with medical problems in which other regimens are contraindicated.

Original languageEnglish
Pages (from-to)365-368
Number of pages4
JournalAnnals of Pharmacotherapy
Issue number3
StatePublished - 1 Jan 2001


  • ACTH
  • Adrenocorticotropic hormone
  • Corticotropin
  • Gout


Dive into the research topics of 'Corticotropin for acute management of gout'. Together they form a unique fingerprint.

Cite this